Home > Inhibitors & Agonists > Others
Cat. No. Product name CAS No.
DC22051 CDD-450

CDD-450 is an unique inhibitor that selectively blocks p38α activation of proinflammatory kinase MAPK-MK2 while sparing p38α activation of PRAK and ATF2.

DC8361 CDDO(Bardoxolone; RTA 401) Featured

CDDO is a synthetic oleanane triterpenoid that blocks the cellular synthesis of inducible nitric oxide synthase and inducible COX-2 in INF-γ-activated mouse macrophages with an IC50 value of 0.4 nM.

218600-44-3
DC12026 CDDO-2P-Imidazolide Featured

CDDO-2P-Im is a new analogue of CDDO-Imidazolid,showing better bioactive than CDDO-Imidazolid.

1883650-96-1
DC12027 CDDO-3P-Imidazolide Featured

CDDO-3P-Im is a new analogue of CDDO-Imidazolid,showing better bioactive than CDDO-Imidazolid.

1883650-95-0
DC20334 CDK2 inhibitor 73 Featured

CDK2 inhibitor 73 is a potent, selective CDK2 inhibitor with IC50 of 44 nM for CDK2/cyclin A, displays 2,000-fold selectivity over CDK1/cyclin B (IC50=86 uM)..

2079895-42-2
DC20921 CDK5 inhibitor 20-223

CDK5 inhibitor 20-223 (CP 668863) potent, selective, ATP-competitive CDK2/5 inhibitor with IC50 of 6.0 and 8.8 nM for CDK2/CyclinE and CDK5/p35, with little to no activity against CDK1/4/6/7/9.

865317-30-2
DC12528 CDK9 inhibitor HH1

CDK9 inhibitor HH1 is a novel potent, highly selective CDK9 inhibitor..

204188-41-0
DC20335 CDK9-IN-8 Featured

CDK9-IN-8 is a highly potent, selective CDK9 inhibitor with IC50 of 12 nM, shows good selectivity in CDKs kinase profiling assay against CDK kinases and cell proliferation inhibition.

2105956-51-0
DC23138 CDK-I73 Featured

CDKI-73 is a potent CDK9 inhibitor with Ki of 4 nM, shows cytotoxicity against a broad CLL samples with mean LD50 of 80 nM.

1421693-22-2
DC11393 CDM-NAG Featured

CDM-NAG is a useful tool compound to deliver the siRNA.

1299292-01-5
DC20879 CDP-840

CDP-840 (CDP840.

162542-90-7
DC20880 CDP-840 hydrochloride

CDP-840 (CDP840.

DC23463 CDPPB Featured

CDPPB is a potent, selective, brain penetrant positive allosteric modulator of mGlu5 receptor with EC50 of 10 nM and 20 nM for human and rat mGluR5, respectively.

781652-57-1
DC22446 CE-224535

CE-224535 (PF-04905428) is a potent and selective P2X7 receptor antagonist with IC50 of 1.4 nM (inhibition of the release of lL-1b from monocytes stimulated by ATP).

724424-43-5
DC20881 CE-245677

CE-245677 is a potent, selective, orally active, dual Tie2/Trk kinase inhibitor with IC50 of 4.7 nM, 1 nM for Tie2 and TrkA/B, respectively.

717899-97-3
DC20336 CE3F4 Featured

CE3F4 is a potent, noncompetitive EPAC1 inhibitor that blocks EPAC1-induced Rap1 activation both in cell-free systems and in intact cells and did not influence protein kinase A holoenzyme activity.

143703-25-7
DC23912 Cecropin B

Cecropin B is an antimicrobial peptide with MICs(0.5 to 16 ug/ml) against Gramnegative strains.

80451-05-4
DC20987 Cedazuridine Featured

Cedazuridine (E7727) is a novel cytidine deaminase inhibitor, and a componet of ASTX727 for treatment of hematologic malignancies..

1141397-80-9
DCAPI1386 Cefdinir (Omnicef)

Cefdinir (Omnicef)

91832-40-5
DC8686 Cefetamet pivoxil hydrochloride

Cefetamet pivoxil hydrochloride is an oral third generation cephalosporin antibiotic.

111696-23-2
DC9358 Cefmenoxime (hydrochloride)

Cefmenoxime hydrochloride is a third-generation cephalosporin antibiotic.

75738-58-8
DCAPI1038 Cefoselis sulfate

Cefoselis sulfate

122841-12-7
Page 160 / Total 1150 FirstPrevNextLastGoto